![Lars Grundemar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lars Grundemar
Direttore/Membro del Consiglio presso
Reccan Diagnostics AB
Health Technology
Profilo
Lars Grundemar is currently the Director at Reccan Diagnostics AB. He was previously the Chief Executive Officer at Oncorena AB and Oncorena Holding AB.
Posizioni attive di Lars Grundemar
| Società | Posizione | Inizio |
|---|---|---|
Reccan Diagnostics AB
 Reccan Diagnostics AB Pharmaceuticals: MajorHealth Technology Provides cancer diagnosis and treatment | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Lars Grundemar
| Società | Posizione | Fine |
|---|---|---|
Oncorena AB
 Oncorena AB Pharmaceuticals: MajorHealth Technology Develops a novel pharmacological treatment for metastasing clear cell renal cancer | Amministratore Delegato | 20/06/2022 |
Oncorena Holding AB
 Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Develops novel pharmacological treatment for metastasing clear cell renal cancer | Amministratore Delegato | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
5
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Oncorena AB
Oncorena AB Pharmaceuticals: MajorHealth Technology Develops a novel pharmacological treatment for metastasing clear cell renal cancer | Health Technology |
Oncorena Holding AB
Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Develops novel pharmacological treatment for metastasing clear cell renal cancer | Health Technology |
Reccan Diagnostics AB
Reccan Diagnostics AB Pharmaceuticals: MajorHealth Technology Provides cancer diagnosis and treatment | Health Technology |
